Common use of Warrant Coverage Clause in Contracts

Warrant Coverage. The Company shall issue to Xxxxxx or its designees at each Closing, warrants (the “Xxxxxx Warrants”) to purchase that number of shares of common stock of the Company equal to 5% of the aggregate number of shares of Common Stock placed in each Offering (if the Securities are convertible or include a “greenshoe” or “additional investment” option component, such shares of Common Stock underlying such Securities or options). If the Securities included in an Offering are non-convertible, the Xxxxxx Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the then market price of the Common Stock. The Xxxxxx Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that the Xxxxxx Warrants shall have an exercise price equal to 125% of the public offering price of an Offering. If no warrants are issued to investors in an Offering, the Xxxxxx Warrants shall be in a customary form reasonably acceptable to Xxxxxx, have a term of 5 years and an exercise price equal to 110% of the then market price of the Common Stock 000 Xxxx Xxxxxx | Xxx Xxxx, Xxx Xxxx 00000 | 212.356.0500 Security services provided by X.X. Xxxxxxxxxx & Co., LLC | Member: FINRA/SIPC

Appears in 2 contracts

Samples: Letter Agreement (Evoke Pharma Inc), Letter Agreement (Evoke Pharma Inc)

AutoNDA by SimpleDocs

Warrant Coverage. The Company shall issue to Xxxxxx or its designees at each Closing, warrants (the “Xxxxxx Warrants”) to purchase that number of shares of common stock of the Company equal to 5% of the aggregate number of shares of Common Stock placed in each Offering (if the Securities are convertible or include a “greenshoe” or “additional investment” option component, such shares of Common Stock underlying such Securities or options). If the Securities included in an Offering are non-convertible, the Xxxxxx Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the then market price of the Common Stock. The Xxxxxx Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that the Xxxxxx Warrants shall have an exercise price equal to 125% of the public offering price of an Offering. If no warrants are issued to investors in an Offering, the Xxxxxx Warrants shall be in a customary form reasonably acceptable to Xxxxxx, have a term of 5 years and an exercise price equal to 110% of the then market price of the Common Stock Stock. 000 Xxxx Xxxxxx | Xxx Xxxx, Xxx Xxxx 00000 | 212.356.0500 Security services provided by X.X. Xxxxxxxxxx & Co., LLC | Member: FINRA/SIPC

Appears in 2 contracts

Samples: Letter Agreement (Cancer Genetics, Inc), Letter Agreement (Cancer Genetics, Inc)

Warrant Coverage. The Company shall issue to Xxxxxx or its designees at each Closing, warrants (the “Xxxxxx Warrants”) to purchase that number of shares of common stock of the Company equal to 5% of the aggregate number of shares of Common Stock placed in each Offering (if the Securities are convertible or include a “greenshoe” or “additional investment” option component, such shares of Common Stock underlying such Securities or options)Offering. If the Securities included in an Offering are non-convertible, the Xxxxxx Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the then market price of the Common Stock. The Xxxxxx Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that the Xxxxxx Warrants shall have a term of five years, and an exercise price equal to 125% of the public per share offering price and shall not have any provisions requiring registration of an Offeringthe underlying shares. If no warrants are issued to investors in an Offering, the Xxxxxx Warrants shall be in a customary form reasonably acceptable to XxxxxxXxxxxx and the Company, have a term of 5 years and an exercise price equal to 110125% of the then market price of the Common Stock Stock. 000 Xxxx Xxxxxx | Xxx Xxxx, Xxx Xxxx 00000 | 212.356.0500 Security services provided by X.X. Xxxxxxxxxx & Co., LLC | Member: FINRA/SIPC

Appears in 1 contract

Samples: Letter Agreement (Hemispherx Biopharma Inc)

Warrant Coverage. The Company shall issue to Xxxxxx or its designees at each Closing, warrants (the “Xxxxxx Warrants”) to purchase that number of shares of common stock of the Company equal to 53 % of the aggregate number of shares of Common Stock placed in each Offering (if the Securities are convertible or include a “greenshoe” or “additional investment” option component, such shares of Common Stock underlying such Securities or options). If the Securities included in an Offering are non-convertible, the Xxxxxx Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the then market price of the Common Stock. The Xxxxxx Warrants 000 Xxxx Xxxxxx | Xxx Xxxx, Xxx Xxxx 00000 | 212.356.0500 Security services provided by X.X. Xxxxxxxxxx & Co., LLC | Member: FINRA/SIPC shall have the same terms as the warrants issued to investors in the applicable Offering, except that the Xxxxxx Warrants shall have an exercise price equal to 125% of the public offering price of an Offering. If no warrants are issued to investors in an Offering, the Xxxxxx Warrants shall be in a customary form reasonably acceptable to Xxxxxx, have a term of 5 years and an exercise price equal to 110% of the then market price of the Common Stock 000 Xxxx Xxxxxx | Xxx Xxxx, Xxx Xxxx 00000 | 212.356.0500 Security services provided by X.X. Xxxxxxxxxx & Co., LLC | Member: FINRA/SIPCStock.

Appears in 1 contract

Samples: Letter Agreement (BioPharmX Corp)

AutoNDA by SimpleDocs

Warrant Coverage. The Company shall issue to Xxxxxx or its designees at each Closing, warrants (the “Xxxxxx Warrants”) to purchase that number of shares of common stock of the Company equal to 55.0% of the aggregate number of shares of Common Stock placed in each Offering (if the Securities are convertible or include a “greenshoe” or “additional investment” option component, such shares of Common Stock underlying such Securities or options). If the Securities included in an Offering are non-convertible, the Xxxxxx Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the then market price of the Common Stock. The Xxxxxx Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that the Xxxxxx Warrants shall have a term of no greater than 5 years and an exercise price equal to 125% of the public offering price of an Offering. If no warrants are issued to investors in an Offering, the Xxxxxx Warrants shall be in a customary form reasonably acceptable to Xxxxxx, have a term of 5 years and an exercise price equal to 110125% of the then market price of the Common Stock Stock. 000 Xxxx Xxxxxx | Xxx Xxxx, Xxx Xxxx 00000 | 212.356.0500 Security services provided by X.X. Xxxxxxxxxx & Co., LLC | Member: FINRA/SIPC

Appears in 1 contract

Samples: Letter Agreement (Apricus Biosciences, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.